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Abstract 
Fetal Alcohol Spectrum Disorders (FASDs) are one of the major causes of preventable developmental delay. There is no register of 
children with FASDs in Ireland. Up to 81% of Irish women report drinking alcohol during the periconceptual period or pregnancy. 
We aimed to evaluate self-reported knowledge and practice of doctors working in paediatrics in Ireland with regards to FASDs and 
alcohol consumption during pregnancy. We circulated a survey to all paediatric doctors in Ireland, either enrolled in specialist 
training or registered as trainers. Fifty-six respondents (31.3%) were unaware of the existence of FASDs. Sixty-two (34.6%) 
believed most patients with FASDs have dysmorphic features. Seventy-three respondents (40.8%) routinely ask about maternal 
alcohol consumption during pregnancy in the context of developmental delay. Thirty-one respondents (17.3%) stated that mild 
alcohol intake in the third trimester of pregnancy is safe. Our survey suggests prenatal alcohol exposure may not be routinely 
considered in the evaluation of children with developmental delay by paediatric doctors in Ireland. 
Introduction 
Fetal Alcohol Spectrum Disorders (FASDs) are characterised by variable mental, physical, neurological and behavioural deficits, 
and are recognised internationally as a major contributor to intellectual impairment and disability, and one of the major causes of 
preventable developmental delay; true prevalence is unknown, but is estimated at 1-5% of all children in North American studies1,2. 
FASDs make a significant contribution to hidden disability as many affected patients have long delays before a diagnosis is made 
or are never diagnosed at all1. 
The umbrella of FASD includes Fetal Alcohol Syndrome (FAS), Partial Fetal Alcohol Syndrome (pFAS), Neurobehavioural Disorder 
associated with Prenatal Alcohol Exposure (ND-PAE) and Alcohol-related Birth Defects (ARBD). Fetal Alcohol Syndrome 
comprises only 10-15% of all cases, and over 75% of children with FASDs have no dysmorphic features to suggest an underlying 
aetiology to a clinician1,3. Diagnosing these conditions is challenging, and recent research suggests only half of American Academy 
of Paediatrics members are confident in their ability to make the diagnosis3. 
A key current concern is that children with FASDs other than Fetal Alcohol Syndrome may go undiagnosed due to the absence of 
dysmorphic features, a lack of accurate information regarding prenatal alcohol exposure, and the frequent incidence of comorbid 
neurodevelopmental or psychiatric conditions in children with FASDs; many cases of FASDs present with chronic mental health or 
neurodevelopmental problems1,2. 
No quantity of alcohol has been proven to be safe to consume during pregnancy; neither is any period of pregnancy immune to the 
effects of alcohol on the fetus1,2,4,5. Any alcohol consumption by expectant mothers at any point during pregnancy, including the third 
trimester, could be associated with adverse outcomes for the fetus, particularly given the frequency of binge drinking in Ireland6,7. 
Alcohol also increases the risk of miscarriage and premature delivery6,7. Adverse outcomes have been reported in Irish and 
international studies across low, moderate, and high levels of periconceptual alcohol exposure1,5,8,9. 
Historically, the lack of a precise dose-response relationship has led to inconsistent advice from healthcare providers and 
professional bodies with regards to the safety of alcohol in pregnancy1,3,7,8. Complete abstinence is now recommended in national 
guidelines for the USA, UK, Canada, New Zealand and Australia1,9. Recent Irish studies have found that 75-81% of expectant 
mothers in Ireland reported consuming alcohol in the periconceptual period7,8. One of these, a retrospective study covering 1987-
2005, found that the majority of expectant mothers reduced their alcohol intake during pregnancy, and 27.6% abstained 
completely7.  Nonetheless, it concluded that “the risk of alcohol related foetal (sic) harm in Ireland is high” and that systemic change 
would be required to support paediatricians and other doctors in the assessment and diagnosis of children exposed to alcohol in 
utero7. 
Doctors involved in the care of babies and children have a unique opportunity to identify children with problems related to alcohol 
exposure in utero. Research suggests that with early diagnosis and intervention, the impact of FASDs on a given child can be 
reduced; children with FASDs have a unique profile of needs and respond differently to treatments than children with other 
neurodevelopmental problems1,3,5,9,11-13. The lack of data regarding the prevalence of FASDs in Ireland in comparison to published 




We circulated an online survey by email in June 2015 to all paediatric doctors in Ireland who were either enrolled in specialist 
training programmes (Senior House Officers or Specialist Registrars), or registered as trainers (Consultant Paediatricians). Total 
population 309; a sample of 172 was required for a margin of error of +/- 5% and 95% confidence interval. In anticipation of a 
response rate of 50-60% based on previous similar surveys, we emailed all eligible potential participants inviting them to complete 
the survey. Our survey consisted of multiple “agree/ disagree/ don’t know” questions regarding individual reported experience in 
diagnosing and managing Fetal Alcohol Spectrum Disorders, diagnostic criteria for Fetal Alcohol Syndrome and attitudes toward 
maternal alcohol consumption in pregnancy. Non-identifying demographic information was collected. Ethical approval was granted 








One hundred and seventy-nine responses were received (58% response rate): demographics are detailed in Table 1. 
 
Experience with FASDs 
 
Results from questions relating to respondents’ experience with FASDs are detailed in Table 2. Consultants were found to have 
more experience and knowledge in this domain, but were also more likely to state that an FASD diagnosis would not make any 
difference to the management of a child with developmental delay (16, 18.6%). Fifty-six respondents (31.3%) across all grades 
were unaware of the existence of FASDs, including 19.8% of consultants. While 81% of respondents had encountered a patient 
with Fetal Alcohol Syndrome, only 24% had encountered a patient with other FASDs. A significant minority (34.6%) believed most 
patients with FASDs have dysmorphic features. Twenty-two respondents (12.3%) reported they had received formal education or 




Diagnostic criteria for Fetal Alcohol Syndrome 
Respondents were presented with a list of physical features and findings, and asked to identify the ones included in the diagnostic 
criteria for Fetal Alcohol Syndrome. Figure 1 displays the number of correct responses for each of the component criteria. Correct 
answers were similar across all grades, with no more than a 5% difference noted between SHOs, Registrars and Consultants for 
any of the features. Senior House Officers were more likely to incorrectly include other features, most commonly micrognathia 
(n=16; 43.2%), cardiac malformations (n=15; 40.5%) and seizures (n=15; 40.5%). 
 
*total number of respondents = 179 
Maternal alcohol consumption in pregnancy 
Table 3 details the responses to questions about maternal alcohol consumption in pregnancy. In the context of a child with 
developmental delay, 73 respondents (40.8%) routinely ask about maternal alcohol consumption during pregnancy (50% of 
consultants); 94 (52.5%) stated they find it difficult to elicit a history of alcohol intake. A significant minority stated that they felt 
uncomfortable discussing alcohol intake with parents (61, 34.1%), while 30 (16.8%) felt that discussing alcohol consumption could 
cause parental anger or upset and negatively affect the child’s treatment. Only 2.8% of respondents stated that a safe level of 
alcohol consumption in pregnancy had been proven, but 17.3% stated that mild alcohol intake in the third trimester of pregnancy is 
safe. One hundred and fifty-one respondents (84.4%) felt that a national awareness campaign with regards to FASDs and alcohol 
consumption during pregnancy would be useful. 
 
Discussion 
The majority of those surveyed reported that they do not routinely discuss maternal alcohol consumption in the context of 
developmental delay in children. Just over 17% believe mild alcohol intake in the third trimester is safe. Furthermore, almost one 
third were unaware of the existence of FASDs and over one third of respondents believed that most children with FASDs have 
dysmorphic features. 
These results suggest that paediatric doctors in Ireland may not routinely consider alcohol as a potential aetiological factor in the 
evaluation of children with developmental delay. Seventy-five percent of children with FASDs have no dysmorphic features or 
growth restriction1, and in the context of our results we hypothesize that in the absence of such features children with FASDs may 
go undiagnosed; this has been reported in other countries1,3,11. The lack of specific training reported by respondents in this area may 
be contributory. 
Only 24% of respondents reported having encountered a patient with FASDs other than Fetal Alcohol Syndrome. If international 
data indicating prevalence rates of over 1% of the total child population are to be believed 1,4,5,9, it is likely that most respondents 
have encountered children with undiagnosed FASDs. 
Just over 18% of consultants believed a diagnosis of FASD would not positively affect a child’s treatment. Research suggests that 
children with FASDs benefit from prompt diagnosis and early intervention with input from speech and language therapists, 
physiotherapy, occupational therapy and classroom support; it is possible to reduce the extent to which children are affected by the 
social, emotional, intellectual and behavioural problems associated with FASDs1,3,5,9,11,12. Children with FASDs may have co-existent 
autism or ADHD, but have different treatment needs and responses to children without FASDs11,12. Children with FASD and ADHD 
have poorer academic performance and a different profile of antisocial and behavioural problems than children with FASD alone11,12. 
Diagnosis before the age of six years has been shown to improve outcome13. 
Just over 17% respondents believe that “mild” alcohol intake in the third trimester is safe. We suggest that if alcohol is not 
considered harmful it is less likely to be considered in the diagnostic process. No level of alcohol consumption has ever been 
proven safe during pregnancy, and adverse child health outcomes and diagnoses of FASDs (including FAS) have been reported at 
even mild levels of reported alcohol consumption1,6,8,13,14. The prevalence of alcohol use during pregnancy in Ireland, despite a lack 
of evidence for any safe limit for alcohol consumption in pregnancy, is a significant public health concern and a target for 
intervention6-8,10. FASDs are 100% preventable if mothers abstain from alcohol consumption while pregnant, and previous research 
suggests health professionals do not always offer consistent advice in this regard1,5,9. 
Doubtless, there are other considerations. Alcohol may not be discussed routinely if another aetiology is readily apparent. Fetal 
Alcohol Spectrum Disorders are technically challenging to diagnose, and share some features with other disorders, including some 
which can exist as co-morbidities alongside FASDs (e.g. autism, ADHD). Opinions from a number of specialists may be sought 
before a diagnosis is reached, and genetic investigations may be indicated. This is before one considers understandable concerns 
about causing unnecessary guilt or anger in mothers which may arise from questions about alcohol consumption1,3. Furthermore, 
standardised assessment and treatment pathways are not currently in operation for children with FASDs in Ireland. 
It is worth acknowledging, as affirmed by the The International Charter for Prevention of Fetal Alcohol Spectrum Disorder5, that 
mothers should not be exposed to this kind of guilt or blame; alcohol consumption occurs within a larger cultural and social context 
and addressing these is more complex than simply improving awareness of FASDs amongst health professionals. However, 
professionals have an opportunity and a responsibility to offer expectant mothers accurate advice about the risks of alcohol 
consumption during pregnancy and to remain vigilant for its consequences. 
Our study has a number of limitations. It is a survey of self-reported knowledge and practice, rather than an observational study of 
practice habits and diagnosis. Twenty-two consultants were working in specialties in which contact with or diagnosis of FASDs 
would not be a common occurrence. Furthermore, it is a study of paediatric doctors only; it would be interesting to ascertain the 
practices of doctors working in other specialties, as well as those of midwives, nurses and other health professionals. Paediatric 
doctors are not chiefly involved in antenatal counselling, and so our attitudes to alcohol consumption during pregnancy have a 
limited impact in this area. We only surveyed doctors involved in training or registered as trainers with RCPI; this was for survey 
distribution reasons. The performance of individuals in this survey cannot be extrapolated to imply the performance of medical 
teams or of the health system as a whole; senior doctors performed better in many areas of this survey, and may act as a safety 
net for their more junior colleagues. We do not infer that the results of this survey are the only factors contributing to the lack of 
recognition given to FASDs in Ireland. 
International data regarding the prevalence of FASDs and Irish data regarding alcohol consumption suggest that Fetal Alcohol 
Spectrum Disorders are a significant hidden public health issue in Ireland1,4-8,10-13. This will only begin to be addressed when the 
disease burden is measured; defining the current practices of doctors in the evaluation of developmental delay in the context of 
alcohol consumption is a key step. Our results suggest conversations about alcohol are often not included in the routine evaluation 
of developmental delay in children in Ireland. The fact that a majority of those surveyed indicated that further training would be 
welcomed is a source for optimism but a more far-reaching multiagency approach will be required to begin to address the burden of 
FASDs. 
Correspondence: 
Irwin Gill, Children’s University Hospital, Temple Street, Dublin 1 
Email: irwingill@gmail.com 
Acknowledgements 
The authors would like to thank all of our colleagues who took the time to respond to this survey. 
Conflicts of Interest 
On behalf of all authors, the corresponding author states that there are no conflicts of interest 
References 
1. Williams JF, Smith VC. Fetal Alcohol Spectrum Disorders. Pediatrics. 2015 Nov;136:e1395-406 
2. Muralidharan P, Sarmah S, Zhou FC, Marrs JA: Fetal Alcohol Spectrum Disorder (FASD) Associated Neural Defects: Complex 
Mechanisms and Potential Therapeutic Targets; Brain Sci. 2013 Jun 19;3:964-91 
3. Gahagan S, Telfair Sharpe T, Brimacombe M. Pediatricians’ Knowledge, Training and Experience in the Care of Children with 
Fetal Alcohol Syndrome; Pediatrics 2006; 118; e657 
4. May PA, Gossage JP, Kalberg WO, Robinson LK, Buckley D, Manning M, Hoyme HE. Prevalence and epidemiologic 
characteristics of FASD from various research methods with an emphasis on recent in-school studies. Dev Disabil Res Rev. 2009; 
15: 176–190 
5. Jonsson E, Salmon A, Warren KR. The international charter on prevention of fetal alcohol spectrum disorder. Lancet Global 
Health. 2014 Mar; 2:e135-7 
6. McCarthy FP, O’Keeffe LM, Khashan AS, North RA, Poston L, McCowan LM, Baker PN, Dekker GA, Roberts CT, Walker JJ, 
Kenny LC. Association between maternal alcohol consumption in early pregnancy and pregnancy outcomes. Obstet Gynecol. 
2013;122:830 
7. Barry S, Kearney A, Daly S, Lawlor E, McNamee E, Barry J. The Coombe Women’s Hospital study of alcohol, smoking and illicit 
drug use 1987 – 2005; Dublin; 2007. 
8. Mullally A, Cleary B, Barry J, Fahey TP, Murphy DJ. Prevalence, predictors and perinatal outcomes of peri-conceptional alcohol 
exposure - retrospective cohort study in an urban obstetric population in Ireland. BMC Pregnancy Childbirth. 2011; 11: 27. 
9. American Academy of Pediatrics. Joint Call to Action on Alcohol and Pregnancy. AAP; 2012; Illinois. (available online at 
https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/fetal-alcohol-spectrum-disorders-toolkit/Pages/Joint-Call-to-
Action-on-Alcohol-and-Pregnancy.aspx) 
10. Ní Shúilleabháin A, Barry J, Kelly A, O'Kelly F, Darker C, O'Dowd T. Alcohol consumption in pregnancy: results from the 
general practice setting. Ir J Med Sci. 2014 Jun;183:231-40 
11. Chasnoff IJ, Wells AM, King L. Misdiagnosis and Missed Diagnoses in Foster and Adopted Children With Prenatal Alcohol 
Exposure. Pediatrics 2015 Feb;135:264-70 
12. Oesterheld JR, Kofoed L, Tervo R, Fogas B, Wilson A, Fiechtner H. Effectiveness of methylphenidate in Native American 
children with fetal alcohol syndrome and attention deficit/hyperactivity disorder: a controlled pilot study. J Child Adolesc 
Psychopharmacol. 1998;8:39–48 
13. Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'Malley K, Young JK. Risk factors for adverse life outcomes in fetal 
alcohol syndrome and fetal alcohol effects. Developmental and Behavioral Pediatrics. 2004; 5: 228-238 
14. Lewis SJ, Zuccolo L, Davey Smith G, Macleod J, Rodriguez S, Draper ES, Barrow M, Alati R, Sayal K, Ring S, Golding J, Gray 
R. Fetal alcohol exposure and IQ at age 8: evidence from a population-based birth-cohort study. PLoS One. 2012;7:e49407 
P528 
 
